NASDAQ: INBXInhibrx Biosciences Inc Stock Ownership - Who owns Inhibrx Biosciences?
Insider buying vs selling
Have Inhibrx Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jon Faiz Kayyem | Director | 2024-11-20 | 18,750 | $14.19 | $266.10kBuy |
| Jon Faiz Kayyem | Director | 2024-11-20 | 18,750 | $14.19 | $266.10kBuy |
| Jon Faiz Kayyem | Director | 2024-11-19 | 34,843 | $14.23 | $495.71kBuy |
| Jon Faiz Kayyem | Director | 2024-11-19 | 34,843 | $14.23 | $495.71kBuy |
| Kristiina Md Vuori | Director | 2024-10-03 | 6,667 | $15.00 | $100.01kBuy |
| Mark Lappe | Chief Executive Officer | 2024-09-16 | 13,037 | $17.13 | $223.32kBuy |
| Mark Lappe | Chief Executive Officer | 2024-09-12 | 26,963 | $15.05 | $405.79kBuy |
| Kristiina Md Vuori | Director | 2024-09-11 | 6,457 | $15.07 | $97.31kBuy |
| Mark Lappe | Chief Executive Officer | 2024-09-10 | 8,500 | $15.19 | $129.12kBuy |
| Kristiina Md Vuori | Director | 2024-09-10 | 179 | $15.00 | $2.69kBuy |
INBX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INBX insiders and whales buy or sell their stock.
INBX Shareholders
What type of owners hold Inhibrx Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Viking Global Investors LP | 12.35% | 1,787,705 | $20.34M | Institution |
| Sanofi | 8.00% | 1,157,926 | $13.18M | Institution |
| Inhibrx Inc | 8.00% | 1,157,926 | $13.18M | Insider |
| Perceptive Advisors LLC | 7.35% | 1,064,026 | $12.11M | Institution |
| Jon Faiz Kayyem | 7.32% | 1,059,046 | $12.05M | Insider |
| Mark Lappe | 7.26% | 1,050,413 | $11.95M | Insider |
| Blackrock Inc | 5.75% | 831,807 | $9.47M | Institution |
| Hightower Advisors LLC | 5.40% | 781,752 | $8.90M | Institution |
| Vanguard Group Inc | 4.20% | 607,721 | $6.92M | Institution |
| Walleye Capital LLC | 4.01% | 579,999 | $6.60M | Institution |
INBX vs Biotech Stocks
Inhibrx Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.